NICE says yes to Novartis’ multiple sclerosis therapy KesimptaNovartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just Share XNICE says yes to Novartis’ multiple sclerosis therapy Kesimptahttps://pharmaphorum.com/news/nice-says-yes-to-novartis-multiple-sclerosis-therapy-kesimpta/
NICE unveils five year plan promising faster access to medicinesNICE has included proposals to speed up evaluations and focus on new technology such as digital health in Share XNICE unveils five year plan promising faster access to medicineshttps://pharmaphorum.com/news/nice-unveils-five-year-plan-promising-faster-access-to-medicines/
EMA starts review of GSK/Vir COVID-19 antibodyThe EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech’s COVID-19 antibody VIR-7831, which Share XEMA starts review of GSK/Vir COVID-19 antibodyhttps://pharmaphorum.com/news/ema-starts-review-of-gsk-vir-covid-19-antibody/
World Orphan Drug Congress USA Virtual 2021World Orphan Drug Congress USA Virtual Share XWorld Orphan Drug Congress USA Virtual 2021https://pharmaphorum.com/events/world-orphan-drug-congress-usa-virtual-2021/
Three pillars of post-pandemic launch excellenceIQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity Share XThree pillars of post-pandemic launch excellencehttps://pharmaphorum.com/views-and-analysis/three-pillars-of-post-pandemic-launch-excellence/
NICE recommends Alexion’s long-acting Ultomiris for PNHNICE has recommended Alexion’s long-acting Ultomiris (ravulizumab) for the rare disease paroxysmal nocturnal haemoglobinuria (PNH) in final draft Share XNICE recommends Alexion’s long-acting Ultomiris for PNHhttps://pharmaphorum.com/news/nice-recommends-alexions-long-acting-ultomiris-for-pnh/
Czech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotsThe Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, Share XCzech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotshttps://pharmaphorum.com/news/czech-republic-swoops-for-denmarks-2-4m-unwanted-az-covid-shots/
Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovationWhen it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. The pharma organisation prides Share XGlobal impact: How regulatory affairs is shaping development of cutting-edge pharma innovationhttps://pharmaphorum.com/views-and-analysis/global-impact-how-regulatory-affairs-is-shaping-development-of-cutting-edge-pharma-innovation/
England begins Moderna vaccine rollout as lockdown easesEngland is beginning its rollout of the Moderna COVID-19 vaccine, offering an alternative to the AstraZeneca/Oxford University jab Share XEngland begins Moderna vaccine rollout as lockdown easeshttps://pharmaphorum.com/news/england-begins-moderna-vaccine-rollout-as-lockdown-eases/